142 related articles for article (PubMed ID: 38807682)
1. Lymph node myeloid sarcoma with TP53‑associated myelodysplastic syndrome: A case report.
Mao M; Deng S
Oncol Lett; 2024 Jul; 28(1):324. PubMed ID: 38807682
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
3. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype,
Wang N; Yuan L; Jing Y; Fan K; Jin H; Lv C; Wang L; Yu L
Leuk Lymphoma; 2021 Oct; 62(10):2466-2474. PubMed ID: 33904352
[TBL] [Abstract][Full Text] [Related]
4. Bladder Myeloid Sarcoma with
Mandhan N; Yassine F; Li K; Badar T
Leuk Res Rep; 2022; 17():100286. PubMed ID: 34976720
[TBL] [Abstract][Full Text] [Related]
5. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.
Sato K; Tsukada N; Inamura J; Komatsu S; Sato K; Yamamoto M; Shindo M; Moriichi K; Mizukami Y; Fujiya M; Torimoto Y; Okumura T
Case Rep Hematol; 2021; 2021():6640597. PubMed ID: 33976945
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and prognosis of mutant TP53 acute myeloid leukemia and myelodysplastic syndrome with excess blasts.
Shen K; Hu DY; Zhang ZB; Guo YS; Zhang FH; Chen SN
Int J Lab Hematol; 2023 Jun; 45(3):344-352. PubMed ID: 36860196
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group.
Samborska M; Barańska M; Wachowiak J; Skalska-Sadowska J; Thambyrajah S; Czogała M; Balwierz W; Kołtan S; Peszyńska-Żelazny K; Wysocki M; Ociepa T; Urasiński T; Wróbel G; Węcławek-Tompol J; Ukielska B; Chybicka A; Kitszel A; Krawczuk-Rybak M; Szmydki-Baran A; Malinowska I; Matysiak M; Mizia-Malarz A; Tomaszewska R; Szczepański T; Chodała-Grzywacz A; Karolczyk G; Maciejka-Kembłowska L; Irga-Jaworska N; Badowska W; Dopierała M; Kurzawa P; Derwich K
Front Oncol; 2022; 12():935373. PubMed ID: 35875115
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
Zhou X; Mei C; Zhang J; Lu Y; Lan J; Lin S; Zhang Y; Kuang Y; Ren Y; Ma L; Wei J; Ye L; Xu W; Li K; Lu C; Jin J; Tong H
Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Niparuck P; Police P; Noikongdee P; Siriputtanapong K; Limsuwanachot N; Rerkamnuaychoke B; Chuncharunee S; Siriboonpiputtana T
Diagn Pathol; 2021 Oct; 16(1):100. PubMed ID: 34717674
[TBL] [Abstract][Full Text] [Related]
11. Myeloid sarcoma: an uncommon presentation of myeloid neoplasms; a case series of 4 rare cases reported in a tertiary care institute.
Jadhav T; Baveja P; Sen A
Autops Case Rep; 2021; 11():e2021339. PubMed ID: 34805008
[TBL] [Abstract][Full Text] [Related]
12. Breast myeloid sarcoma presenting as a palpable breast lump after allogeneic stem cell transplantation for acute myelomonocytic leukemia: a rare case report.
Huang C; Fei S; Yao J; Chen P; Luo J; Wang Y; Li J; Wang W
World J Surg Oncol; 2021 Sep; 19(1):289. PubMed ID: 34579724
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia.
Byrd JC; Edenfield WJ; Dow NS; Aylesworth C; Dawson N
Leuk Lymphoma; 1996 Mar; 21(1-2):153-9. PubMed ID: 8907283
[TBL] [Abstract][Full Text] [Related]
14. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
15. TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Current Guidelines, Therapies, and Future Considerations.
DiGennaro J; Sallman DA
Acta Haematol; 2024; 147(2):175-185. PubMed ID: 38052186
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].
Xu XS; Ding H; Zhang X; Liao Y; Li H; Liu QY; Liu JZ; Zhang L; Huang J; Gong YP; Ma HB; Xiang B; Dai Y; Hou L; Shuai X; Niu T; Wu Y
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):742-748. PubMed ID: 38049318
[No Abstract] [Full Text] [Related]
17. Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Grob T; Al Hinai ASA; Sanders MA; Kavelaars FG; Rijken M; Gradowska PL; Biemond BJ; Breems DA; Maertens J; van Marwijk Kooy M; Pabst T; de Weerdt O; Ossenkoppele GJ; van de Loosdrecht AA; Huls GA; Cornelissen JJ; Beverloo HB; Löwenberg B; Jongen-Lavrencic M; Valk PJM
Blood; 2022 Apr; 139(15):2347-2354. PubMed ID: 35108372
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
Lazzarotto D; Candoni A; Filì C; Forghieri F; Pagano L; Busca A; Spinosa G; Zannier ME; Simeone E; Isola M; Borlenghi E; Melillo L; Mosna F; Lessi F; Fanin R
Leuk Res; 2017 Feb; 53():74-81. PubMed ID: 28056398
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Estey EH; Thall PF; Pierce S; Cortes J; Beran M; Kantarjian H; Keating MJ; Andreeff M; Freireich E
Blood; 1999 Apr; 93(8):2478-84. PubMed ID: 10194425
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation.
Yalniz FF; Greenbaum U; Pasvolsky O; Milton DR; Kanagal-Shamanna R; Ramdial J; Srour S; Mehta R; Alousi A; Popat UR; Nieto Y; Kebriaei P; Al-Atrash G; Oran B; Hosing C; Ahmed S; Champlin RE; Shpall EJ; Qazilbash MH; Bashir Q
Transplant Cell Ther; 2024 Feb; 30(2):205.e1-205.e12. PubMed ID: 37437764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]